Product NDC: | 61703-348 |
Proprietary Name: | Epirubicin Hydrochloride |
Non Proprietary Name: | EPIRUBICIN HYDROCHLORIDE |
Active Ingredient(s): | 200 mg/100mL & nbsp; EPIRUBICIN HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-348 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050807 |
Marketing Category: | NDA |
Start Marketing Date: | 20060915 |
Package NDC: | 61703-348-59 |
Package Description: | 100 mL in 1 VIAL, SINGLE-USE (61703-348-59) |
NDC Code | 61703-348-59 |
Proprietary Name | Epirubicin Hydrochloride |
Package Description | 100 mL in 1 VIAL, SINGLE-USE (61703-348-59) |
Product NDC | 61703-348 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPIRUBICIN HYDROCHLORIDE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060915 |
Marketing Category Name | NDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |